Travers Smith has advised its long-standing client Inflexion on its investment in GlobalData Plc's ("GlobalData") Healthcare division. Inflexion is partnering with GlobalData to carve out its Healthcare division as a standalone entity in a transaction valuing the business at £1.1 billion. The investment is being made by Inflexion's dedicated minority equity strategy, Partnership Capital.
The healthcare data business is the largest division of AIM-listed GlobalData, headquartered in the UK and employing over 1,000 people across 10 countries. Its subscription service offers a one-stop data solution for over 2,000 global customers across large global pharma, pharma & biotech, pharma suppliers, professional services and medical devices manufacturers.
David Whileman, Partner and Head of Partnership Capital at Inflexion, said: "GlobalData is renowned for creating data and analytical insight for its clients across many verticals. We are really excited about our partnership with them to carve out and expand an independent Healthcare division. This is a tried and tested strategy we've successfully pursued many times and another example of Inflexion being the leading minority investment partner."
The Travers Smith team was led by the Head of Private Equity & Financial Sponsors Lucie Cawood and Private Equity and Financial Sponsors Partner Tom Hartwright, supported by Senior Counsel Joanna Roberts, Senior Associate Max Conway and Associates Tom Morrish, Sam Van Besouw, Alexandra Dawson and Nora Bjørnstad, and Trainee Michael Puvanesan. Advice in relation to PLC aspects was provided by Corporate M&A and ECM Partner Richard Spedding and Senior Associate Ella Sharpley. Tax advice was provided by Tax Partner Hannah Manning, Senior Associate Kyle Rainsford and Associate Ross McGregor. Commercial advice was provided by Technology & Commercial Transactions Partner James Longster and Senior Associate Sarah Robinson.
